• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study.

作者信息

Li Pulin, Huang Ling, Han Rui, Tang Min, Fei Guanghe, Zeng Daxiong, Wang Ran

机构信息

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China.

Department of Infectious Disease, Hefei Second People's Hospital, Hefei, China.

出版信息

Clin Transl Med. 2024 Jun;14(6):e1673. doi: 10.1002/ctm2.1673.

DOI:10.1002/ctm2.1673
PMID:38840331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11154803/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/11154803/3baafd793a81/CTM2-14-e1673-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/11154803/db84d0668416/CTM2-14-e1673-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/11154803/36e8cdd120e3/CTM2-14-e1673-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/11154803/3baafd793a81/CTM2-14-e1673-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/11154803/db84d0668416/CTM2-14-e1673-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/11154803/36e8cdd120e3/CTM2-14-e1673-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/11154803/3baafd793a81/CTM2-14-e1673-g003.jpg

相似文献

1
Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study.机器学习与影像组学预测程序性细胞死亡蛋白1抑制剂治疗小细胞肺癌的疗效：一项多中心队列研究
Clin Transl Med. 2024 Jun;14(6):e1673. doi: 10.1002/ctm2.1673.
2
Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.基于计算机断层扫描成像的放射组学与临床病理特征相结合，预测肺癌免疫检查点抑制剂的临床获益。
Respir Res. 2021 Jun 28;22(1):189. doi: 10.1186/s12931-021-01780-2.
3
Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review.晚期非小细胞肺癌患者中抗 PD-1 和抗 PD-L1 抗体免疫检查点抑制剂再挑战时的给药切换：病例系列和文献复习。
Thorac Cancer. 2020 Jul;11(7):1927-1933. doi: 10.1111/1759-7714.13483. Epub 2020 May 18.
4
Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis.肺癌合并特发性肺纤维化患者的免疫检查点阻断治疗
Eur J Cancer. 2021 Mar;145:179-182. doi: 10.1016/j.ejca.2020.12.016. Epub 2021 Jan 22.
5
[Immuno-checkpoint inhibitor resistance and strategy in lung cancer].[肺癌中的免疫检查点抑制剂耐药性及策略]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jul 12;43(7):603-606. doi: 10.3760/cma.j.cn112147-20200312-00319.
6
Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancer.既往胸部放疗对晚期非小细胞肺癌免疫检查点抑制剂疗效的影响。
Jpn J Clin Oncol. 2021 Feb 8;51(2):279-286. doi: 10.1093/jjco/hyaa180.
7
Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer.基于机器学习的非小细胞肺癌免疫检查点抑制剂治疗预测指标
Ann Oncol. 2019 Apr 1;30(4):655-657. doi: 10.1093/annonc/mdz049.
8
Using MRI radiomics to predict the efficacy of immunotherapy for brain metastasis in patients with small cell lung cancer.利用 MRI 放射组学预测小细胞肺癌脑转移患者免疫治疗的疗效。
Thorac Cancer. 2024 Mar;15(9):738-748. doi: 10.1111/1759-7714.15259. Epub 2024 Feb 20.
9
Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 Inhibitors.抗程序性死亡 1 抑制剂治疗晚期非小细胞肺癌中预测临床获益和免疫相关不良事件的血液细胞因子。
Clin Lung Cancer. 2021 Nov;22(6):e833-e841. doi: 10.1016/j.cllc.2021.04.007. Epub 2021 Apr 27.
10
Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors.抗生素和质子泵抑制剂对 PD-1 免疫检查点抑制剂疗效和耐受性的影响。
Front Immunol. 2021 Oct 27;12:716317. doi: 10.3389/fimmu.2021.716317. eCollection 2021.

本文引用的文献

1
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)].[中国医学协会肺癌临床诊疗指南（2023年版）]
Zhonghua Zhong Liu Za Zhi. 2023 Jul 23;45(7):539-574. doi: 10.3760/cma.j.cn112152-20230510-00200.
2
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing.塞普鲁单抗联合化疗对比化疗治疗美国和中国广泛期小细胞肺癌患者的成本效果分析：为药物定价提供信息。
BioDrugs. 2023 May;37(3):421-432. doi: 10.1007/s40259-023-00586-6. Epub 2023 Feb 25.
3
LGBMDF: A cascade forest framework with LightGBM for predicting drug-target interactions.
LGBMDF：一种结合LightGBM的级联森林框架，用于预测药物-靶点相互作用。
Front Microbiol. 2023 Jan 5;13:1092467. doi: 10.3389/fmicb.2022.1092467. eCollection 2022.
4
Serplulimab: First Approval.西普单抗：首次批准。
Drugs. 2022 Jul;82(10):1137-1141. doi: 10.1007/s40265-022-01740-0. Epub 2022 Jul 7.
5
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options.广泛期小细胞肺癌：一线和二线治疗选择。
J Clin Oncol. 2022 Feb 20;40(6):671-680. doi: 10.1200/JCO.21.01881. Epub 2022 Jan 5.
6
LightBBB: computational prediction model of blood-brain-barrier penetration based on LightGBM.LightBBB：基于 LightGBM 的血脑屏障穿透性计算预测模型。
Bioinformatics. 2021 May 23;37(8):1135-1139. doi: 10.1093/bioinformatics/btaa918.
7
Lung Cancer 2020: Epidemiology, Etiology, and Prevention.肺癌 2020：流行病学、病因学和预防。
Clin Chest Med. 2020 Mar;41(1):1-24. doi: 10.1016/j.ccm.2019.10.001.
8
Immunotherapy: a new era in small-cell lung cancer.免疫疗法：小细胞肺癌的新时代。
Lancet. 2019 Nov 23;394(10212):1884-1885. doi: 10.1016/S0140-6736(19)32235-4. Epub 2019 Oct 4.
9
Computational Radiomics System to Decode the Radiographic Phenotype.用于解码影像学表型的计算放射组学系统
Cancer Res. 2017 Nov 1;77(21):e104-e107. doi: 10.1158/0008-5472.CAN-17-0339.
10
Small-cell lung cancer.小细胞肺癌。
Lancet. 2011 Nov 12;378(9804):1741-55. doi: 10.1016/S0140-6736(11)60165-7. Epub 2011 May 10.